ZHI TAN to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications ZHI TAN has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.116
-
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nat Med. 2018 05; 24(5):638-646.
Score: 0.116